BC. re GIA. ...remember the reaction to GIA late 2012 . AMRN ( from memory ) lost about 1/3rd of its value ....even before it got to the 2013 Adcom ambush. So this time we're down less , with $200m of new money , an approved product on the market , Outcome trial results , an up an running sales force with TV ads ....and the threat of another Adcom ( for expanded indication ) ...well off in the distance. Cheer up Kiwi
Market Data 
Markets 
AI
